They demonstrate that STAT3 signaling is blocked when Prx2-dependent STAT3 oxidation is not counterbalanced by the Trx/TrxR/NADPH system, leading to the death of tumor cells that depend on STAT3 signaling. Here, PRDX2 is linked to neoplasm.